Furthermore, the expression of p-mTOR, mTORC1, mTORC2, STAT3, Akt, p-Akt, CDK6, and NF-κB, in U251 and U87MG cells were significantly downregulated by GBM-N019 treatment (Figure 4E). This evidence concerns the gene MTOR and glioblastoma.